| 2902.90.10 | 00 | Pseudocumene | kg | Free | | Free |
| 2909.50.40 | 10 | Eugenol and isoeugenol | kg | | | |
| 2921.49.38 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.99.58 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents: | | | | |
| 2934.30.23 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2936.29.15 | 10 | Pharmaceutical grade | kg | | | |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.50.00 | 00 | Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues | g | Free | | 25% |
| 2939.42.00 | 00 | Pseudoephedrine and its salts | kg | Free | | 15.4￠/kg + 59% |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3003 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: | | | | |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
| 3004.40.00 | 30 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | | | |
| 3004.90.91 | 35 | Antidepressants, tranquilizers, and other psychotherapeutic agents | kg | | | |
| 3005 | | Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes: | | | | |
| 3005.10.10 | 00 | Coated or impregnated with pharmaceutical substances | kg | Free | | 20% |
| 3005.90.10 | 00 | Coated or impregnated with pharmaceutical substances | kg | Free | | 20% |
| 3006 | | Pharmaceutical goods specified in note 4 to this chapter: | | | | |
| 3006.92.00 | 00 | Waste pharmaceuticals | kg | Free | | 45% |
| 3201.90.25 | 00 | Extracts of canaigre, chestnut, curupay, divi-divi, eucalyptus, gambier, hemlock, larch, mangrove, myrobalan, oak, sumac, tara, urunday or valonia | kg | Free | | Free |
| 3301 | | Essential oils (terpeneless or not), including concretes and absolutes; resinoids; extracted oleoresins; concentrates of essential oils in fats, in fixed oils, in waxes or the like, obtained by enfleurage or maceration; terpenic by- products of the deterpenation of essential oils; aqueous distillates and aqueous solutions of essential oils: | | | | |
